{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T06:31:10Z","timestamp":1778999470895,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":43,"publisher":"Springer New York","isbn-type":[{"value":"9781493991983","type":"print"},{"value":"9781493991990","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-1-4939-9199-0_17","type":"book-chapter","created":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T11:02:53Z","timestamp":1553943773000},"page":"205-213","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The Pneumococcus and Its Critical Role in Public Health"],"prefix":"10.1007","author":[{"given":"Godwin","family":"Oligbu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norman K.","family":"Fry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamez N.","family":"Ladhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,31]]},"reference":[{"issue":"9693","key":"17_CR1","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","volume":"374","author":"KL O\u2019Brien","year":"2009","unstructured":"O\u2019Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N et al (2009) Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374(9693):893\u2013902","journal-title":"Lancet"},{"issue":"12","key":"17_CR2","first-page":"93","volume":"82","author":"World Health Organization","year":"2007","unstructured":"World Health Organization (2007) Pneumococcal conjugate vaccine for childhood immunization - WHO position paper. Wkly Epidemiol Rec 82(12):93\u2013104","journal-title":"Wkly Epidemiol Rec"},{"key":"17_CR3","unstructured":"European Centre for Disease Prevention and Control (2017) Invasive pneumococcal disease. Stockholm. https:\/\/ecdc.europa.eu\/en\/publications-data\/invasive-pneumococcal-disease-annual-epidemiological-report-2017 . Accessed 12 May 2018"},{"key":"17_CR4","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S1473-3099(10)70048-7","volume":"10","author":"K Edmond","year":"2010","unstructured":"Edmond K, Clark A, Korczak VS et al (2010) Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis 10:317\u2013328","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"17_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1741-7015-7-47","volume":"7","author":"M Ramakrishnan","year":"2009","unstructured":"Ramakrishnan M, Ulland AJ, Steinhardt LC, Mo\u00efsi JC, Were F et al (2009) Sequelae due to bacterial meningitis among African children: a systematic literature review. BMC Med 7(1):47","journal-title":"BMC Med"},{"key":"17_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.mimet.2015.03.006","volume":"113","author":"E Jauneikaite","year":"2015","unstructured":"Jauneikaite E, Tocheva AS, Jefferies JM, Gladstone RA, Faust SN, Christodoulides M et al (2015) Current methods for capsular typing of Streptococcus pneumoniae. J Microbiol Methods 113:41\u201349. https:\/\/doi.org\/10.1016\/j.mimet.2015.03.006 . Epub 2015 Mar 25","journal-title":"J Microbiol Methods"},{"key":"17_CR7","doi-asserted-by":"publisher","first-page":"e2477","DOI":"10.7717\/peerj.2477","volume":"4","author":"G Kapatai","year":"2016","unstructured":"Kapatai G, Sheppard CL, Al-Shahib A, Litt DJ, Underwood AP, Harrison TG et al (2016) Whole genome sequencing of Streptococcus pneumoniae: development, evaluation and verification of targets for serogroup and serotype prediction using an automated pipeline. PeerJ 4:e2477. https:\/\/doi.org\/10.7717\/peerj.2477 . eCollection 2016","journal-title":"PeerJ"},{"key":"17_CR8","volume-title":"A fatal form of septicaemia in the rabbit produced by the subcutaneous injection of human saliva: an experimental research","author":"GM Sternberg","year":"1881","unstructured":"Sternberg GM (1881) A fatal form of septicaemia in the rabbit produced by the subcutaneous injection of human saliva: an experimental research. John Murphy Co., Baltimore"},{"key":"17_CR9","first-page":"159","volume":"92","author":"L Pasteur","year":"1881","unstructured":"Pasteur L (1881) Sur une maladie nouvelle, provoqu\u00e9 par la salive d\u00fan enfant mort de la rage. C R Acad Sci 92:159","journal-title":"C R Acad Sci"},{"issue":"3","key":"17_CR10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1128\/JB.5.3.191-229.1920","volume":"5","author":"CE Winslow","year":"1920","unstructured":"Winslow CE, Broadhurst J, Buchanan RE, Krumwiede C, Rogers LA, Smith GH (1920) The families and genera of the bacteria: final report of the committee of the society of American bacteriologists on characterization and classification of bacterial types. J Bacteriol 5(3):191\u2013229","journal-title":"J Bacteriol"},{"key":"17_CR11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1084\/jem.54.1.73","volume":"54","author":"OT Avery","year":"1931","unstructured":"Avery OT, Dubos R (1931) The protective action of a specific enzyme against type III pneumococcus infections in mice. J Exp Med 54:73\u201389","journal-title":"J Exp Med"},{"issue":"3","key":"17_CR12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2105\/AJPH.28.3.293","volume":"28","author":"WG Smillie","year":"1938","unstructured":"Smillie WG, Warnock GH, White HJ (1938) A study of a type I pneumococcus epidemic at the state hospital at Worcester, Mass. Am J Public Health Nations Health 28(3):293\u2013302","journal-title":"Am J Public Health Nations Health"},{"issue":"3","key":"17_CR13","first-page":"226","volume":"10","author":"A Fleming","year":"1929","unstructured":"Fleming A (1929) On the antibacterial action of cultures of a penicillin, with special reference to their use in isolation of B. influenzae. Br J Exp Pathol 10(3):226\u2013236","journal-title":"Br J Exp Pathol"},{"key":"17_CR14","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1001\/jama.1943.02840350001001","volume":"122","author":"CS Keefer","year":"1943","unstructured":"Keefer CS, Blake FG, Marshall EK Jr, Lockwood JS, Wood BW Jr (1943) Penicillin in the treatment of infections: a report of 500 cases. JAMA 122:1217\u20131224","journal-title":"JAMA"},{"key":"17_CR15","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1056\/NEJM197810052991402","volume":"299","author":"MR Jacobs","year":"1978","unstructured":"Jacobs MR, Koornhof HJ, Robins-Browne RM et al (1978) Emergence of multiply resistant pneumococci. N Engl J Med 299:735\u2013740","journal-title":"N Engl J Med"},{"key":"17_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1084\/jem.24.1.49","volume":"24","author":"LM Stryker","year":"1916","unstructured":"Stryker LM (1916) Variations in the pneumococcus induced by growth in immune serum. J Exp Med 24:49\u201368","journal-title":"J Exp Med"},{"key":"17_CR17","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1101\/SQB.1951.016.01.032","volume":"16","author":"RD Hotchkiss","year":"1951","unstructured":"Hotchkiss RD (1951) Transfer of penicillin resistance in pneumococci by the desoxyribonucleate derived from resistant cultures. Cold Spring Harb Symp Quant Biol 16:457\u2013461","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"1","key":"17_CR18","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1086\/313608","volume":"30","author":"WP Hausdorff","year":"2000","unstructured":"Hausdorff WP, Bryant J, Paradiso PR, Siber GR (2000) Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 30(1):100\u2013121","journal-title":"Clin Infect Dis"},{"issue":"6","key":"17_CR19","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1093\/infdis\/148.6.1136","volume":"148","author":"JB Robbins","year":"1983","unstructured":"Robbins JB, Austrian R, Lee CJ, Rastogi SC, Schiffman G, Henrichsen J et al (1983) Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis 148(6):1136\u20131159","journal-title":"J Infect Dis"},{"issue":"34","key":"17_CR20","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.1016\/j.vaccine.2014.03.017","volume":"32","author":"AJ Hoek Van","year":"2014","unstructured":"Van Hoek AJ, Sheppard CL, Andrews NJ, Waight PA, Slack MPE, Harrison TG et al (2014) Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England. Vaccine 32(34):4349\u20134355","journal-title":"Vaccine"},{"issue":"16","key":"17_CR21","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1001\/jama.294.16.2043","volume":"294","author":"CA Lexau","year":"2005","unstructured":"Lexau CA, Lynfield R, Danila R, Pilishvili T, Facklam R, Farley MM et al (2005) Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 294(16):2043\u20132051","journal-title":"JAMA"},{"issue":"RR-9","key":"17_CR22","first-page":"1","volume":"49","author":"Advisory Committee on Immunization Practices","year":"2000","unstructured":"Advisory Committee on Immunization Practices (2000) Preventing pneumococcal disease among infants and young children. Recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 49(RR-9):1\u201335","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"17_CR23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/cid\/cir325","volume":"53","author":"M Deutscher","year":"2011","unstructured":"Deutscher M, Lewis M, Zell ER, Taylor TH Jr, Van Beneden C et al (2011) Incidence and severity of invasive streptococcus pneumoniae, group A streptococcus, and group B streptococcus infections among pregnant and postpartum women. Clin Infect Dis 53(2):114\u2013123","journal-title":"Clin Infect Dis"},{"issue":"5","key":"17_CR24","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/cid\/cis934","volume":"56","author":"SN Ladhani","year":"2012","unstructured":"Ladhani SN, Andrews NJ, Waight P, Borrow R, Slack MP, Miller E (2012) Impact of the 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in infants younger than 90 days in England and Wales. Clin Infect Dis 56(5):633\u2013640","journal-title":"Clin Infect Dis"},{"issue":"6","key":"17_CR25","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1128\/JCM.00275-06","volume":"44","author":"A Kronenberg","year":"2006","unstructured":"Kronenberg A, Zucs P, Droz S, Muhlemann K (2006) Distribution and invasiveness of Streptococcus pneumoniae serotypes in Switzerland, a country with low antibiotic selection pressure, from 2001 to 2004. J Clin Microbiol 44(6):2032\u20132038","journal-title":"J Clin Microbiol"},{"issue":"5","key":"17_CR26","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1086\/505710","volume":"194","author":"KL Sleeman","year":"2006","unstructured":"Sleeman KL, Griffiths D, Shackley F, Diggle L, Gupta S, Maiden MC et al (2006) Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. J Infect Dis 194(5):682\u2013688","journal-title":"J Infect Dis"},{"issue":"9","key":"17_CR27","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1086\/374624","volume":"187","author":"AB Brueggemann","year":"2003","unstructured":"Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW et al (2003) Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis 187(9):1424\u20131432","journal-title":"J Infect Dis"},{"issue":"4","key":"17_CR28","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1128\/JCM.01763-10","volume":"49","author":"R S\u00e1-Le\u00e3o","year":"2011","unstructured":"S\u00e1-Le\u00e3o R, Pinto F, Aguiar S, Nunes S, Carri\u00e7o JA, Fraz\u00e3o N et al (2011) Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype. J Clin Microbiol 49(4):1369\u20131375","journal-title":"J Clin Microbiol"},{"issue":"12","key":"17_CR29","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1007\/s10096-011-1247-5","volume":"30","author":"IA Rivera-Olivero","year":"2011","unstructured":"Rivera-Olivero IA, del Nogal B, Sisco MC, Bogaert D, Hermans PW et al (2011) Carriage and invasive isolates of Streptococcus pneumoniae in Caracas, Venezuela: the relative invasiveness of serotypes and vaccine coverage. Eur J Clin Microbiol Infect Dis 30(12):1489\u20131495","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"17_CR30","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.vaccine.2010.10.032","volume":"29","author":"I Yildirim","year":"2010","unstructured":"Yildirim I, Hanage WP, Lipsitch M, Shea KM, Stevenson A, Finkelstein J et al (2010) Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease. Vaccine 29:283\u2013288","journal-title":"Vaccine"},{"issue":"5","key":"17_CR31","doi-asserted-by":"publisher","first-page":"e1000081","DOI":"10.1371\/journal.pmed.1000081","volume":"6","author":"ZB Harboe","year":"2009","unstructured":"Harboe ZB, Thomsen RW, Riis A, Valentiner-Branth P, Christensen JJ, Lambertsen L et al (2009) Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med 6(5):e1000081\u2013e1000081","journal-title":"PLoS Med"},{"issue":"6","key":"17_CR32","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1086\/655828","volume":"51","author":"DM Weinberger","year":"2010","unstructured":"Weinberger DM, Harboe ZB, Sanders EAM, Ndiritu M, Klugman KP, R\u00fcckinger S et al (2010) Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis 51(6):692\u2013699","journal-title":"Clin Infect Dis"},{"key":"17_CR33","first-page":"A22","volume":"103","author":"G Oligbu","year":"2018","unstructured":"Oligbu G, Djennad A, Collins S, Sheppard NK, Fry NK, Borrow R et al (2018) Impact of pneumococcal conjugate vaccines on pneumococcal meningitis in England and Wales, 2000\u20132016. Arch Dis Child 103:A22","journal-title":"Arch Dis Child"},{"issue":"Supplement_1","key":"17_CR34","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1093\/clinids\/24.Supplement_1.S85","volume":"24","author":"A Tomasz","year":"1997","unstructured":"Tomasz A (1997) Antibiotic resistance in Streptococcus pneumoniae. Clin Infect Dis 24(Supplement_1):S85\u2013S88","journal-title":"Clin Infect Dis"},{"issue":"2","key":"17_CR35","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/cid\/cix310","volume":"65","author":"G Oligbu","year":"2017","unstructured":"Oligbu G, Collins S, Sheppard CL, Fry NK, Slack M, Borrow R et al (2017) Childhood deaths attributable to invasive pneumococcal disease in England and Wales, 2006\u20132014. Clin Infect Dis 65(2):308\u2013314","journal-title":"Clin Infect Dis"},{"issue":"1","key":"17_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3201\/eid1901.120741","volume":"19","author":"SN Ladhani","year":"2013","unstructured":"Ladhani SN, Slack MP, Andrews NJ, Waight PA, Borrow R, Miller E (2013) Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children England and Wales. Emerg Infect Dis 19(1):61","journal-title":"Emerg Infect Dis"},{"issue":"16","key":"17_CR37","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1001\/jama.297.16.1784","volume":"297","author":"RJ Singleton","year":"2007","unstructured":"Singleton RJ, Hennessy TW, Bulkow LR, Hammitt LL, Zulz T, Hurlburt DA et al (2007) Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 297(16):1784\u20131792","journal-title":"JAMA"},{"key":"17_CR38","unstructured":"Centers for Disease Control and Prevention (2013) Active bacterial core surveillance report, emerging infections program network, streptococcus pneumoniae, 2011. Accessed 12 May 2018"},{"issue":"RR-11","key":"17_CR39","first-page":"1","volume":"59","author":"JP Nuorti","year":"2010","unstructured":"Nuorti JP, Whitney CG (2010) Prevention of pneumococcal disease among infants and children: use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine: recommendations of the advisory committee on immunization practices (ACIP). Department of Health and Human Services, Centers for Disease Control and Prevention. MMWR Recomm Rep 59(RR-11):1\u201318","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"17_CR40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jinf.2012.02.017","volume":"65","author":"AJ Hoek Van","year":"2012","unstructured":"Van Hoek AJ, Andrews N, Waight PA, Stowe J, Gates P, George R et al (2012) The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England. J Infect 65(1):17\u201324","journal-title":"J Infect"},{"key":"17_CR41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1473-3099(07)70242-6","volume":"8","author":"SJ Bliss","year":"2008","unstructured":"Bliss SJ, O\u2019Brien KL, Janoff EN, Cotton MF, Musoke P, Coovadia H et al (2008) The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease. Lancet Infect Dis 8:67\u201380","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"17_CR42","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/QAD.0b013e328341b7f1","volume":"25","author":"MC Nunes","year":"2011","unstructured":"Nunes MC, Von Gottberg A, de Gouveia L et al (2011) The impact of antiretroviral treatment on the burden of invasive pneumococcal disease in South African children: a time series analysis. AIDS 25(4):453\u2013462","journal-title":"AIDS"},{"issue":"7","key":"17_CR43","first-page":"643","volume":"103","author":"G Oligbu","year":"2018","unstructured":"Oligbu G, Collins S, Sheppard C, Fry N, Dick M, Streetly A, Ladhani S. (2018). Risk of Invasive Pneumococcal Disease in Children with Sickle Cell Disease in England: A National Observational Cohort Study, 2010\u20132015. Archives of disease in childhood, 103(7):643\u2013647","journal-title":"Archives of disease in childhood"}],"container-title":["Methods in Molecular Biology","Streptococcus pneumoniae"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-9199-0_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T01:30:22Z","timestamp":1607131822000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-9199-0_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9781493991983","9781493991990"],"references-count":43,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-9199-0_17","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"31 March 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}